John O'Gorman

ORCID

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 10

Top Venues

Alzheimer's & dementia : the journal of the Alzheimer's Association

Neurology

This page only lists publications with an associated author ORCID identifier.

Publications

Tianle Chen, John O'Gorman, Carmen Castrillo-Viguera, Rajasimhan Rajagovindan, Gioacchino G Curiale, Ying Tian, Dakshaben Patel, Philipp von Rosenstiel, Christian von Hehn, Stephen Salloway, Christoph Hock, Roger M Nitsch, Samantha Budd Haeberlein, Alfred Sandrock, Priya Singhal
Results from the long-term extension of PRIME: A randomized Phase 1b trial of aducanumab. Alzheimer's & dementia : the journal of the Alzheimer's Association 20 (5) (2024)
Tianle Chen, John O'Gorman, Carmen Castrillo-Viguera, Rajasimhan Rajagovindan, Gioacchino G Curiale, Ying Tian, Dakshaben Patel, Philipp von Rosenstiel, Christian von Hehn, Stephen Salloway, Christoph Hock, Roger M Nitsch, Samantha Budd Haeberlein, Alfred Sandrock, Priya Singhal
Results from the long-term extension of PRIME: A randomized Phase 1b trial of aducanumab. Alzheimer's & dementia : the journal of the Alzheimer's Association 20 (5) (2024)
Tianle Chen, John O'Gorman, Carmen Castrillo-Viguera, Rajasimhan Rajagovindan, Gioacchino G Curiale, Ying Tian, Dakshaben Patel, Philipp von Rosenstiel, Christian von Hehn, Stephen Salloway, Christoph Hock, Roger M Nitsch, Samantha Budd Haeberlein, Alfred Sandrock, Priya Singhal
Results from the long-term extension of PRIME: A randomized Phase 1b trial of aducanumab. Alzheimer's & dementia : the journal of the Alzheimer's Association 20 (5) (2024)
Tianle Chen, John O'Gorman, Carmen Castrillo-Viguera, Rajasimhan Rajagovindan, Gioacchino G Curiale, Ying Tian, Dakshaben Patel, Philipp von Rosenstiel, Christian von Hehn, Stephen Salloway, Christoph Hock, Roger M Nitsch, Samantha Budd Haeberlein, Alfred Sandrock, Priya Singhal
Results from the long-term extension of PRIME: A randomized Phase 1b trial of aducanumab. Alzheimer's & dementia : the journal of the Alzheimer's Association 20 (5) (2024)
Tianle Chen, John O'Gorman, Carmen Castrillo-Viguera, Rajasimhan Rajagovindan, Gioacchino G Curiale, Ying Tian, Dakshaben Patel, Philipp von Rosenstiel, Christian von Hehn, Stephen Salloway, Christoph Hock, Roger M Nitsch, Samantha Budd Haeberlein, Alfred Sandrock, Priya Singhal
Results from the long-term extension of PRIME: A randomized Phase 1b trial of aducanumab. Alzheimer's & dementia : the journal of the Alzheimer's Association (2024)
Tianle Chen, John O'Gorman, Carmen Castrillo-Viguera, Rajasimhan Rajagovindan, Gioacchino G Curiale, Ying Tian, Dakshaben Patel, Philipp von Rosenstiel, Christian von Hehn, Stephen Salloway, Christoph Hock, Roger M Nitsch, Samantha Budd Haeberlein, Alfred Sandrock, Priya Singhal
Results from the long-term extension of PRIME: A randomized Phase 1b trial of aducanumab. Alzheimer's & dementia : the journal of the Alzheimer's Association 20 (5) (2024)
Stephanie J Loomis, Ryan Miller, Carmen Castrillo-Viguera, Kimberly Umans, Wenting Cheng, John O'Gorman, Richard Hughes, Samantha Budd Haeberlein, Christopher D Whelan
Genome-Wide Association Studies of ARIA From the Aducanumab Phase 3 ENGAGE and EMERGE Studies. Neurology 102 (3) (2023)
Stephanie J Loomis, Ryan Miller, Carmen Castrillo-Viguera, Kimberly Umans, Wenting Cheng, John O'Gorman, Richard Hughes, Samantha Budd Haeberlein, Christopher D Whelan
Genome-Wide Association Studies of ARIA From the Aducanumab Phase 3 ENGAGE and EMERGE Studies. Neurology 102 (3) (2023)
Stephanie J Loomis, Ryan Miller, Carmen Castrillo-Viguera, Kimberly Umans, Wenting Cheng, John O'Gorman, Richard Hughes, Samantha Budd Haeberlein, Christopher D Whelan
Genome-Wide Association Studies of ARIA From the Aducanumab Phase 3 ENGAGE and EMERGE Studies. Neurology 102 (3) (2023)
Stephanie J Loomis, Ryan Miller, Carmen Castrillo-Viguera, Kimberly Umans, Wenting Cheng, John O'Gorman, Richard Hughes, Samantha Budd Haeberlein, Christopher D Whelan
Genome-Wide Association Studies of ARIA From the Aducanumab Phase 3 ENGAGE and EMERGE Studies. Neurology 102 (3) (2023)

John O'Gorman.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

John O'Gorman